AMGEN INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that AMGEN INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $25.42B | Feb 9, 2021 |
| FY2020 | Dec 31, 2019 | $23.36B | Feb 9, 2021 |
| FY2020 | Dec 31, 2018 | $23.75B | Feb 9, 2021 |
| FY2019 | Dec 31, 2017 | $22.85B | Feb 12, 2020 |
| FY2018 | Dec 31, 2016 | $22.99B | Feb 13, 2019 |
| FY2017 | Dec 31, 2015 | $21.66B | Feb 13, 2018 |
| FY2016 | Dec 31, 2014 | $20.06B | Feb 14, 2017 |
| FY2015 | Dec 31, 2013 | $18.68B | Feb 16, 2016 |
| FY2014 | Dec 31, 2012 | $17.27B | Feb 19, 2015 |
| FY2013 | Dec 31, 2011 | $15.58B | Feb 24, 2014 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $36.75B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $33.42B | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $28.19B | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $26.32B | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $25.98B | Feb 14, 2024 |
| FY2022 | Dec 31, 2020 | $25.42B | Feb 9, 2023 |
| FY2021 | Dec 31, 2019 | $23.36B | Feb 16, 2022 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.71B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $4.09B | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $6.72B | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $6.55B | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $5.89B | Feb 14, 2024 |
| FY2020 | Dec 31, 2020 | $1.62B | Feb 9, 2021 |
| FY2020 | Sep 30, 2020 | $2.02B | Feb 9, 2021 |
| FY2020 | Jun 30, 2020 | $1.80B | Feb 9, 2021 |
| FY2020 | Mar 31, 2020 | $1.83B | Feb 9, 2021 |
| FY2020 | Dec 31, 2019 | $1.70B | Feb 9, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.08B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $7.26B | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $7.90B | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | $9.57B | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | $7.64B | Feb 14, 2024 |
| FY2022 | Dec 31, 2020 | $9.14B | Feb 9, 2023 |
| FY2021 | Dec 31, 2019 | $9.67B | Feb 16, 2022 |
| FY2020 | Dec 31, 2018 | $10.26B | Feb 9, 2021 |
| FY2019 | Dec 31, 2017 | $9.97B | Feb 12, 2020 |
| FY2018 | Dec 31, 2016 | $9.79B | Feb 13, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $90.59B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $91.84B | Feb 13, 2026 |
| FY2024 | Dec 31, 2023 | $97.15B | Feb 14, 2025 |
| FY2023 | Dec 31, 2022 | $65.12B | Feb 14, 2024 |
| FY2022 | Dec 31, 2021 | $61.17B | Feb 9, 2023 |
| FY2021 | Dec 31, 2020 | $62.95B | Feb 16, 2022 |
| FY2020 | Dec 31, 2019 | $59.71B | Feb 9, 2021 |
| FY2019 | Dec 31, 2018 | $66.42B | Feb 12, 2020 |
| FY2018 | Dec 31, 2017 | $79.95B | Feb 13, 2019 |
| FY2017 | Dec 31, 2016 | $77.63B | Feb 13, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.66B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $5.88B | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | $6.23B | Feb 13, 2026 |
| FY2025 | Dec 31, 2022 | $3.66B | Feb 13, 2026 |
| FY2024 | Dec 31, 2021 | $6.70B | Feb 14, 2025 |
| FY2023 | Dec 31, 2020 | $9.41B | Feb 14, 2024 |
| FY2022 | Dec 31, 2019 | $9.67B | Feb 9, 2023 |
| FY2021 | Dec 31, 2018 | $12.50B | Feb 16, 2022 |
| FY2020 | Dec 31, 2017 | $25.24B | Feb 9, 2021 |
| FY2019 | Dec 31, 2016 | $29.88B | Feb 12, 2020 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 14 | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | 7 | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | 12 | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | 12 | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | 10 | Feb 14, 2024 |
| FY2020 | Dec 31, 2020 | 2 | Feb 9, 2021 |
| FY2020 | Sep 30, 2020 | 3 | Feb 9, 2021 |
| FY2020 | Jun 30, 2020 | 3 | Feb 9, 2021 |
| FY2020 | Mar 31, 2020 | 3 | Feb 9, 2021 |
| FY2020 | Dec 31, 2019 | 2 | Feb 9, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 14 | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | 7 | Feb 13, 2026 |
| FY2025 | Dec 31, 2023 | 12 | Feb 13, 2026 |
| FY2024 | Dec 31, 2022 | 12 | Feb 14, 2025 |
| FY2023 | Dec 31, 2021 | 10 | Feb 14, 2024 |
| FY2020 | Dec 31, 2020 | 2 | Feb 9, 2021 |
| FY2020 | Sep 30, 2020 | 3 | Feb 9, 2021 |
| FY2020 | Jun 30, 2020 | 3 | Feb 9, 2021 |
| FY2020 | Mar 31, 2020 | 3 | Feb 9, 2021 |
| FY2020 | Dec 31, 2019 | 2 | Feb 9, 2021 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.13B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $11.97B | Feb 13, 2026 |
| FY2024 | Dec 31, 2023 | $10.94B | Feb 14, 2025 |
| FY2023 | Dec 31, 2022 | $7.63B | Feb 14, 2024 |
| FY2022 | Dec 31, 2021 | $7.99B | Feb 9, 2023 |
| FY2021 | Dec 31, 2020 | $6.27B | Feb 16, 2022 |
| FY2020 | Dec 31, 2019 | $6.04B | Feb 9, 2021 |
| FY2019 | Dec 31, 2018 | $6.95B | Feb 12, 2020 |
| FY2018 | Dec 31, 2017 | $3.80B | Feb 13, 2019 |
| FY2018 | Dec 31, 2016 | $3.24B | Feb 13, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $54.60B | Feb 13, 2026 |
| FY2025 | Dec 31, 2024 | $60.10B | Feb 13, 2026 |
| FY2024 | Dec 31, 2023 | $64.61B | Feb 14, 2025 |
| FY2023 | Dec 31, 2022 | $38.95B | Feb 14, 2024 |
| FY2022 | Dec 31, 2021 | $33.31B | Feb 9, 2023 |
| FY2021 | Dec 31, 2020 | $32.99B | Feb 16, 2022 |
| FY2020 | Dec 31, 2019 | $29.90B | Feb 9, 2021 |
| FY2019 | Dec 31, 2018 | $33.93B | Feb 12, 2020 |
| FY2018 | Dec 31, 2017 | $35.34B | Feb 13, 2019 |
| FY2017 | Dec 31, 2016 | $34.60B | Feb 13, 2018 |